All forms of AD share disrupted metabolism of APP and/or its metabolites; however, mutated or excess APP is the primary driver of disease in the cases of early onset AD examined, whereas in late onset AD APOE status is the principal genetic risk factor, suggesting potential differences in underlying pathomechanisms despite similarities in clinical presentation. Here, APOE is linked to Alzheimer disease.